title: Hypotensive effect of the active fragment derived from factor XII is mediated by an activation of the plasma kallikrein-kinin system.
abstract: Plasma protein fraction (PPF) contaminated by factor XII active fragment (XIIf) may cause hypotensive reactions when infused to patients. This study was planned to assess in conscious normotensive rats whether the blood pressure response to the factor XIIf is mediated by an activation of the plasma kallikrein-kinin system or by stimulation of prostaglandin synthesis. To test whether the factor XIIf-induced blood pressure fall is due partially to an enhanced generation of vasodilating prostaglandins, the blood pressure effect of XIIf (1 microgram i.v.) was investigated 15 min after treatment with indomethacin (5 mg i.v.), an inhibitor of cyclo-oxygenase. Factor XIIf reduced mean blood pressure similarly in indomethacin- and vehicle-treated rats (-23 +/- 4 mmHg, n = 5, and -23 +/- 5 mmHg, n = 4, respectively). Other rats received factor XIIf 15 min after depletion of circulating prekallikrein by the administration of dextran sulfate. Thirty minutes after a 0.25 mg i.v. dose of this agent, plasma prekallikrein activity averaged 0.12 +/- 0.015 mumol/min/ml (n = 6) as compared to 2.48 +/- 0.31 mumol/min/ml in control rats (n = 4, P less than .001). Factor XIIf decreased mean blood pressure by only 4 +/- 2 mm Hg in rats pretreated with dextran sulfate. Thus, it was possible to blunt the acute hypotensive effect of factor XIIf by depleting circulating prekallikrein, but not by inhibiting prostaglandin production. This strongly suggests that the blood pressure effects of factor XIIf is mediated by a stimulation of the plasma kallikrein-kinin system.
authors: Division of Hypertension, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
authors: G
authors: G
authors: Waeber
authors: M
authors: M
authors: Schapira
authors: B
authors: B
authors: Waeber
authors: J F
authors: JF
authors: Aubert
authors: J
authors: J
authors: Nussberger
authors: H R
authors: HR
authors: Brunner
mesh_terms: D000818:Animals; D001794:Blood Pressure / Q000187:drug effects*; D001920:Bradykinin / Q000097:blood*; D016861:Cyclooxygenase Inhibitors; D016264:Dextran Sulfate; D003911:Dextrans / Q000494:pharmacology; D005174:Factor XII / Q000378:metabolism / Q000494:pharmacology*; D007213:Indomethacin / Q000494:pharmacology; D007610:Kallikreins / Q000097:blood*; D008297:Male; D010446:Peptide Fragments / Q000494:pharmacology; D011288:Prekallikrein / Q000097:blood; D051381:Rats; D011919:Rats, Inbred Strains
chemical_list: D016861:Cyclooxygenase Inhibitors; D003911:Dextrans; D010446:Peptide Fragments; D005174:Factor XII; D016264:Dextran Sulfate; D011288:Prekallikrein; D007610:Kallikreins; D001920:Bradykinin; D007213:Indomethacin